Predictive Biomarkers Market Size, Growth Drivers And Forecast | Leading Players
Neurodegenerative diseases like Alzheimer's and Parkinson's present significant challenges for diagnosis and treatment. Predictive biomarkers, such as amyloid-beta and tau proteins in Alzheimer's disease, can aid in early detection and tracking disease progression. These biomarkers enable researchers to develop targeted therapies and interventions aimed at slowing or halting the neurodegenerative process, potentially improving patient outcomes and quality of life.